Our goal is to serve as a resource for all Canadians affected by aHUS, and form a nationwide community of aHUS patients.
Soliris® Inhibits TMA and Improves Renal Function in Pediatric and Adult Patients with aHUS
Alexion Pharmaceuticals, Inc. – November 9, 2013
Stay connected with the aHUS community in Canada! To receive info and updates from aHUS Canada, sign up here:
In addition to providing support to patients and caregivers, aHUS Canada strives to connect those affected by the condition to establish a Canadian aHUS community, build public awareness and understanding of this very rare and potentially fatal disease and advocate for the best possible care and treatment for patients.